BioSpace News Archive

Policy

Sandoz Regulatory Submission for Proposed Biosimilar Adalimumab Accepted by FDA

Sandoz announced today that the FDA has accepted its BLA for proposed biosimilar adalimumab to the reference medicine, Humira.

January 16, 2018
·
7 min read
Drug Development

Novartis’ Cosentyx Beats Johnson & Johnson’s Stelara in Head-to-Head Trial

The safety profile of Cosentyx was in line with the known safety profile.

January 16, 2018
·
17 min read
APRINOIA Therapeutics Closes $11M Series B Financing to Advance Its Tau PET Imaging Tracer and Tau Therapeutic Programs for Alzheimer’s Disease

The proceeds of the funding will be used to finance preclinical and clinical development for APRINOIA’s imaging diagnostic and therapeutic pipelines.

January 16, 2018
·
4 min read
Business

Dr. Reddy’s to release Q3 FY18 results on January 25, 2018

Dr. Reddy’s Laboratories Ltd. will announce results for the Third Quarter ended December 31, 2017 on Thursday, January 25, 2018 after the Board Meeting.

January 16, 2018
·
4 min read
Business

Lumosa Therapeutics Licenses Long Acting Injectable Analgesic to Skyline Vet Pharma for Use in Companion Animals

Lumosa Therapeutics and Skyline Vet Pharma today announced a licensing agreement for Lumosa’s CS011.

January 16, 2018
·
2 min read
Deals

Context Therapeutics Announces the Acquisition of Apristor (Onapristone XR), an Investigational Phase II Drug for Metastatic Breast Cancer

Context made a one-time payment to Arno Therapeutics in exchange for the worldwide rights to Apristor.

January 16, 2018
·
3 min read
Business

CollPlant Appoints David Tsur as Chairman of the Board

CollPlant announced the appointment of David Tsur to the position of Chairman of the Board of Directors, effective immediately.

January 16, 2018
·
3 min read
Business

Marken Opens New Kit Building Facility in Shanghai

Marken announced today the opening of a new Kit Building Center in Shanghai, the company’s third location in addition to Hamburg and Singapore.

January 16, 2018
·
2 min read
Business

RepliCel Life Sciences Lands Commitment for Key Investment Partnership

Replicel Life Sciences is pleased to announce it has signed a Binding Term Sheet with YOFOTO to form a strategic partnership in Greater China.

January 16, 2018
·
9 min read
Da Volterra Announces Publication of Full Results from Clinical Trial of DAV132 to Prevent the Disruption of the Microbiome by Antibiotics

The primary endpoints for the study were fully achieved and DAV132 showed an excellent tolerability profile.

January 16, 2018
·
3 min read